Talon Therapeutics, Inc. Reports Fourth Quarter and Year End 2010 Financial Results
28 mars 2011 09h00 HE
|
Talon Therapeutics, Inc.
SAN MATEO, Calif., March 28, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON) today reported financial results for the fourth quarter and full year ended December 31, 2010, and provided...
Talon Therapeutics to Host a Conference Call to Report Fourth Quarter and Full Year 2010 Results and Business Update on March 28, 2011
24 mars 2011 19h49 HE
|
Talon Therapeutics, Inc.
SAN MATEO, Calif., March 24, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON) will host a conference call on Monday, March 28, 2011 at 8am PT, to include a discussion of results and...
Talon Therapeutics to Present at the Roth Capital Partners 23rd Annual OC Growth Stock Conference
14 mars 2011 08h30 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., March 14, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics (OTCBB:TLON), announced that Steven R. Deitcher, M.D., President and Chief Executive Officer, is scheduled to present...
New Patent Issued for Talon Therapeutics' Marqibo(R) Expands Disease Coverage to Include Lymphoma, Leukemia and Myeloma
10 mars 2011 08h30 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., March 10, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON), today announced the issuance of U.S. patent 7,887,836 B2, which covers compositions and methods...
Hana Biosciences to Change Name to Talon Therapeutics
01 déc. 2010 08h30 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 1, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, announced that its...
Hana Biosciences to Present Data on Marqibo(R) at the 2010 American Society of Hematology Annual Meeting and Exposition
29 nov. 2010 09h00 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 29, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
Hana Biosciences Reports Third Quarter 2010 Financial Results
12 nov. 2010 09h00 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences, Inc. (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported...
Hana Biosciences to Host a Conference Call to Report Third Quarter 2010 Results and Business Update on November 12, 2010
08 nov. 2010 17h23 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 8, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences, Inc. (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, will host a...
Hana Biosciences Reverse Stock Split Effective Monday, September 13, 2010
10 sept. 2010 16h05 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 10, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences, Inc. (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced...
Hana Biosciences Reports Second Quarter 2010 Financial Results
13 août 2010 06h15 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 13, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences Inc. (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported...